Ser835
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.6.0.2
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser835  -  PTPN3 (human)

Site Information
VRSLRVDsEPVLVHC   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 451192

In vivo Characterization
Methods used to characterize site in vivo:
mass spectrometry ( 1 )
Disease tissue studied:
hepatocellular carcinoma, surrounding tissue ( 1 )
Relevant cell line - cell type - tissue:
hepatic-'liver, para-hepatocellular carcinoma tissue' ( 1 )

Downstream Regulation
Effects of modification on PTPN3:
molecular association, regulation ( 2 )
Induce interaction with:
14-3-3 beta (human) ( 2 )

References 

1

Tucker M (2009) CST Curation Set: 6571; Year: 2009; Biosample/Treatment: liver, para-hepatocellular carcinoma tissue, hepatic/untreated; Disease: liver cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

2

Zhang SH, et al. (1997) Serine phosphorylation-dependent association of the band 4.1-related protein-tyrosine phosphatase PTPH1 with 14-3-3beta protein. J Biol Chem 272, 27281-7
9341175   Curated Info